NextPlat (NXPL) Non Operating Income (2018 - 2026)
NextPlat's (NXPL) quarterly Non Operating Income came in at $31000.0 in Q2 2026, down 56.34% year-over-year from $71000.0 in Q2 2025, and up 206.9% quarter-over-quarter from -$29000.0 in Q1 2026.
Powered by 
Analysis
NextPlat (NXPL) Non Operating Income (2018 - 2026) Analysis & Trends
NextPlat (NXPL) has reported Non Operating Income for 9 consecutive years, with $31000.0 the latest figure, recorded in Q2 2026.
- On a quarterly basis, Non Operating Income fell 56.34% year-over-year to $31000.0 in Q2 2026; TTM through Jun 2026 was -$1.7 million, a 473.17% decrease from a year earlier, with the FY2025 full-year figure at -$1.5 million, down 356.67% from the prior year.
- Non Operating Income was $31000.0 for Q2 2026 at NextPlat, up from -$29000.0 in the prior quarter.
- Over five years, Non Operating Income peaked at $473000.0 in Q2 2023 and troughed at -$1.5 million in Q4 2025.
- A 5-year average of -$4944.4 and a median of $51000.0 in 2025 frame the typical range for Non Operating Income.
- Across the five-year window, Non Operating Income surged 38100.0% in 2024 and plunged 868.87% in 2025, its largest moves.
- Over 5 years, Non Operating Income stood at $99981.0 in 2022, then soared by 279.07% to $379000.0 in 2023, then tumbled by 139.84% to -$151000.0 in 2024, then sank by 868.87% to -$1.5 million in 2025, then surged by 102.12% to $31000.0 in 2026.
- The last three Non Operating Income figures came in at $31000.0 (Q2 2026), -$29000.0 (Q1 2026), and -$1.5 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.34 Bn | 38.68 Bn | 2.15 Bn | -224.00 Mn |
| 2 | Viatris | 19.39 Bn | 18.50 Bn | 1.46 Bn | - |
| 3 | Dr Reddys Laboratories | 9.99 Bn | 9.85 Bn | 396.53 Mn | - |
| 4 | Amneal Pharmaceuticals | 5.57 Bn | 5.53 Bn | 334.51 Mn | -58.78 Mn |
| 5 | Bausch Health Companies | 2.45 Bn | 1.58 Bn | 2.10 Bn | - |
| 6 | Ani Pharmaceuticals | 1.70 Bn | 1.34 Bn | 165.89 Mn | - |
| 7 | Alvotech | 1.66 Bn | 1.52 Bn | 2.56 Mn | - |
| 8 | Amphastar Pharmaceuticals | 985.90 Mn | 695.77 Mn | 93.47 Mn | -1.19 Mn |
| 9 | Fennec Pharmaceuticals | 434.07 Mn | 392.82 Mn | 17.15 Mn | 278,000.00 |
| 10 | NextPlat | 24.77 Mn | 12.93 Mn | 4.69 Mn | 31,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 31,000.00 |
| Mar 31, 2026 | -29,000.00 |
| Dec 31, 2025 | -1.46 Mn |
| Sep 30, 2025 | -222,000.00 |
| Jun 30, 2025 | 71,000.00 |
| Mar 31, 2025 | 151,000.00 |
| Dec 31, 2024 | -151,000.00 |
| Sep 30, 2024 | 380,000.00 |
| Jun 30, 2024 | 173,000.00 |
| Mar 31, 2024 | 168,000.00 |
| Dec 31, 2023 | 379,000.00 |
| Sep 30, 2023 | -1,000.00 |
| Jun 30, 2023 | 473,000.00 |
| Mar 31, 2023 | 83,000.00 |
| Dec 31, 2022 | 99,981.00 |
| Sep 30, 2022 | -93,901.00 |
| Jun 30, 2022 | -122,612.00 |
| Mar 31, 2022 | -15,468.00 |
| Dec 31, 2021 | -3,355.00 |
| Sep 30, 2021 | -68,703.00 |